Wedbush Raises Earnings Estimates for Rocket Pharmaceuticals
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Investment analysts at Wedbush boosted their Q3 2025 earnings estimates for shares of Rocket Pharmaceuticals in a research note issued to investors on Tuesday, May 27th. Wedbush analyst Y. Zhong now anticipates that the biotechnology company will post earnings per share of ($0.46) for the quarter, up […]
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Investment analysts at Wedbush boosted their Q3 2025 earnings estimates for shares of Rocket Pharmaceuticals in a research note issued to investors on Tuesday, May 27th. Wedbush analyst Y. Zhong now anticipates that the biotechnology company will post earnings per share of ($0.46) for the quarter, up […]
